奎思纳米配方作为皮肤癌的潜在方法
Harshad Kapare1, Sunil Kanadje1, Ritesh Bhole1,2
1Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune411018, Maharashtra, India.
Pharmaceutical nanotechnology
|December 11, 2024
概括
奎尔素是一种天然的抗癌化合物,看起来很有前途,但面临着交付挑战. 纳米载体系统提高了其稳定性和生物可用性,提高了对抗皮肤癌的有效性.
科学领域:
- 自然产品 化学 化学
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 奎尔素是一种黄类化合物,通过抗炎和抗氧化机制表现出抗癌性质.
- 它抑制了NF-κB和COX-2等关键通路,并中和了活性氧物种 (ROS).
- 由于溶解性,生物可用性,稳定性和皮肤透性差,治疗应用受到阻碍.
研究的目的:
- 审查与奎尔塞丁治疗用途相关的挑战.
- 探索纳米载体系统在克服这些局限性的潜力.
- 为了突出通过纳米载体输送的瑞增强的抗癌疗效.
主要方法:
- 审查关于奎尔丁抗癌性质的现有文献.
- 分析各种纳米载体系统 (脂质体,纳米颗粒,纳米乳液) 用于素的输送.
- 评估纳米载体介导的瑞的药理动力学和疗效的改善.
主要成果:
- 纳米载体系统显著提高了氨酸的可溶性,稳定性和生物可用性.
- 通过纳米载体配方实现了增强的皮肤透和有针对性的输送.
- 这些改进转化为对抗皮肤癌的有效性增加.
结论:
- 纳米载体系统代表了一种可行的策略,以克服奎尔塞丁的局限性.
- 像脂质体和纳米颗粒这样的配方增强了奎尔素的抗癌潜力,特别是在皮肤应用中.
- 通过纳米载体的有针对性的输送和受控释放可以改善治疗结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Skin Cancer
3.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.4K


